DrinkWater Family Services Receives the SBB Research Group Foundation Grant
CHICAGO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- DrinkWater Family Services received a $5,000 grant from the SBB Research Group Foundation,...
Read more
Quantum Energy Partners Completes Sale of Tug Hill and XcL Midstream Assets
HOUSTON, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Quantum Capital Group (“Quantum”), a leading provider of capital to the global energy...
Read moreLa-Z-Boy Reports First Quarter Fiscal 2024 Results
Company owned Retail written same-store sales increased 2%Delivered sales and operating margin in line with guidanceGAAP diluted EPS of $0.63;...
Read moreAssociated Capital Group Sets Record Date for 2023 Shareholder Designated Charitable Contribution
GREENWICH, Conn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Associated Capital Group, Inc. (NYSE: AC) has set October 15, 2023 as...
Read moreComplete Solaria Reports Second Quarter 2023 Results
Revenue Segment Performance by Quarter ($ millions) Revenue Segment Performance by Quarter ($ millions) FREMONT, Calif., Aug. 22, 2023 (GLOBE...
Read moreNavios Maritime Holdings Inc. Announces the Date for the Release of Second Quarter Ended June 30, 2023 Results, Conference Call and Webcast
Conference Call & Webcast: Thursday, August 24, 2023 at 8:30 am ETGRAND CAYMAN, Cayman Islands, Aug. 22, 2023 (GLOBE NEWSWIRE)...
Read moreAmerica’s Car-Mart Named One of America’s Greatest Workplaces 2023 by Newsweek
ROGERS, Ark., Aug. 22, 2023 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) has been named to Newsweek’s “America’s Greatest...
Read moreLifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development...
Read moreTPI Composites Manufactures Structural Composites for the Development of the International® SuperTruck II
International® SuperTruck II TPI Composites Manufactures Structural Composites for the Development of the International® SuperTruck II SCOTTSDALE, Ariz., Aug. 22,...
Read moreCelcuity Enters into a Clinical Trial Collaboration and Supply Agreement with Bayer to Provide Nubeqa® (darolutamide) for Planned Phase 1b/2 Clinical Trial
MINNEAPOLIS, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Read moreADVERTISEMENTS
Shortcodes Ultimate
ADVERTISEMENTS
